Literature DB >> 21351313

Role of key informants and direct patient interviews in epidemiological studies of substance abuse.

Theodore J Cicero1, Matthew S Ellis, Alethea Paradis, Zachary Ortbal.   

Abstract

PURPOSE: The present study was undertaken to assess the degree to which key informants' perceptions of relative abuse liability of opioids in their communities correspond to actual drug use in their patients.
METHODS: Key informants (n = 49) and their patients (n = 738) were asked to complete anonymous, independent paper surveys about perceived or actual abuse of nine targeted opioid drugs: buprenorphine, fentanyl, heroin, hydrocodone, hydromorphone, methadone, morphine, oxycodone and tramadol.
RESULTS: There was a strong correspondence (R = 0.98) between KI rankings of relative abuse of opioids in their patient population and the actual rank order calculated from their patients' selection of a primary euphorigenic opioid. The patient surveys not only validated the KI's conclusions, but also provided a great deal of important information about the nature of the abuse patterns. Notably, significant co-morbidity was found in the patient population: 55% had a history of psychiatric problems; chronic pain of moderate intensity was common; 67% were nicotine dependent; and 43% were diagnosed alcoholics. DISCUSSION: Our results demonstrate that KI's perceived rank order of drugs of choice correlated almost perfectly with their patients' choice of a primary drug. These data suggest that key informants, as they have for decades in epidemiological research, provide a reliable, high-level view of substance abuse in their catchment area. As such, KIs provide valid and reliable information on scope and patterns of abuse, but if more detail is required about the characteristics of abuse, such as that required for FDA-mandated Risk Evaluation and Mitigation Strategies, then direct interviews with the abusers themselves seem more appropriate.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 21351313      PMCID: PMC3094596          DOI: 10.1002/pds.2075

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  12 in total

1.  Pediatric disaster preparedness of a hospital network in a large metropolitan region.

Authors:  Rizaldy R Ferrer; Darshi Balasuriya; Ellen Iverson; Jeffrey S Upperman
Journal:  Am J Disaster Med       Date:  2010 Jan-Feb

Review 2.  Foundations of opioid risk management.

Authors:  Nathaniel P Katz; Edgar H Adams; James C Benneyan; Howard G Birnbaum; Simon H Budman; Ronald W Buzzeo; Daniel B Carr; Theodore J Cicero; Douglas Gourlay; James A Inciardi; David E Joranson; James Kesslick; Stephen D Lande
Journal:  Clin J Pain       Date:  2007-02       Impact factor: 3.442

3.  National addictions vigilance intervention and prevention program (NAVIPPRO): a real-time, product-specific, public health surveillance system for monitoring prescription drug abuse.

Authors:  Stephen F Butler; Simon H Budman; Andrea Licari; Theresa A Cassidy; Katherine Lioy; James Dickinson; John S Brownstein; James C Benneyan; Traci Craig Green; Nathaniel Katz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-12       Impact factor: 2.890

4.  Monitoring risk: post marketing surveillance and signal detection.

Authors:  Richard C Dart
Journal:  Drug Alcohol Depend       Date:  2009-09-12       Impact factor: 4.492

5.  Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004.

Authors:  Theodore J Cicero; James A Inciardi; Alvaro Muñoz
Journal:  J Pain       Date:  2005-10       Impact factor: 5.820

6.  A postmarketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States.

Authors:  T J Cicero; E H Adams; A Geller; J A Inciardi; A Muñoz; S H Schnoll; E C Senay; G E Woody
Journal:  Drug Alcohol Depend       Date:  1999-11-01       Impact factor: 4.492

7.  The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).

Authors:  Theodore J Cicero; Richard C Dart; James A Inciardi; George E Woody; Sidney Schnoll; Alvaro Muñoz
Journal:  Pain Med       Date:  2007-03       Impact factor: 3.750

8.  Sex, drugs, and HIV: rapid assessment of HIV risk behaviors among street-based drug using sex workers in Durban, South Africa.

Authors:  Richard Needle; Karen Kroeger; Hrishikesh Belani; Angeli Achrekar; Charles D Parry; Sarah Dewing
Journal:  Soc Sci Med       Date:  2008-08-03       Impact factor: 4.634

Review 9.  The burden of the nonmedical use of prescription opioid analgesics.

Authors:  Aaron M Gilson; Paul G Kreis
Journal:  Pain Med       Date:  2009-07       Impact factor: 3.750

10.  Pain management and substance abuse: a national dilemma.

Authors:  Jeannine Catalano
Journal:  Soc Work Public Health       Date:  2009 Nov-Dec
View more
  6 in total

1.  Detection of signals of abuse and dependence applying disproportionality analysis.

Authors:  V Pauly; M Lapeyre-Mestre; D Braunstein; M Rueter; X Thirion; E Jouanjus; J Micallef
Journal:  Eur J Clin Pharmacol       Date:  2014-11-20       Impact factor: 2.953

2.  Gabapentin prescribed during substance abuse treatment: The perspective of treatment providers.

Authors:  Mance E Buttram; Steven P Kurtz; Matthew S Ellis; Theodore J Cicero
Journal:  J Subst Abuse Treat       Date:  2019-07-21

3.  Comparison of a drug versus money and drug versus drug self-administration choice procedure with oxycodone and morphine in opioid addicts.

Authors:  Sandra D Comer; Verena E Metz; Ziva D Cooper; William J Kowalczyk; Jermaine D Jones; Maria A Sullivan; Jeanne M Manubay; Suzanne K Vosburg; Mary E Smith; Deena Peyser; Phillip A Saccone
Journal:  Behav Pharmacol       Date:  2013-09       Impact factor: 2.293

4.  Data Sources Regarding the Nonmedical Use of Pharmaceutical Opioids in the United States.

Authors:  Teresa Schmidt; Amanuel Zimam; Alexandra Nielsen; Wayne Wakeland
Journal:  Rev Health Care       Date:  2014

5.  Association of bowel and tear suppression with coronary artery disease: A case control study.

Authors:  N Nifina; Anupama Krishnan
Journal:  J Ayurveda Integr Med       Date:  2021-01-11

6.  A qualitative examination of naloxone access in three states: Connecticut, Kentucky, and Wisconsin.

Authors:  Antoinette L Spector; Carol L Galletly; Erika A Christenson; H Danielle Green Montaque; Julia Dickson-Gomez
Journal:  BMC Public Health       Date:  2022-07-19       Impact factor: 4.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.